Proto Script Pharmaceutical Corp. (PSCR) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Proto Script Pharmaceutical Corp. (PSCR) opera en el sector Industrials, cotizado por última vez a $ con una capitalización de mercado de 0.
Ultimo analisis: 18 mar 2026Perfil de Operaciones Industriales de Proto Script Pharmaceutical Corp. (PSCR)
Proto Script Pharmaceutical Corp., founded in 2001, focuses on the niche market of power wheelchair and scooter repair and rental, primarily serving insurance providers. With a high gross margin but negative profit margin, the company operates within the specialty business services sector, facing competition from larger players.
Tesis de Inversión
Investing in Proto Script Pharmaceutical Corp. (PSCR) presents a high-risk, high-reward scenario. The company's high gross margin of 71.5% indicates potential profitability, but the negative profit margin of -910.4% raises concerns about operational efficiency and cost management. Growth catalysts include expanding service offerings and penetrating new geographic markets. However, the company's OTC listing and high beta of 6.35 suggest significant volatility and speculative interest. Investors should closely monitor PSCR's ability to improve its bottom line and manage its financial risks. The company's reliance on insurance providers for revenue also exposes it to regulatory changes and reimbursement pressures.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Gross Margin of 71.5% indicates strong potential for profitability in core operations.
- Negative Profit Margin of -910.4% signals significant challenges in cost management and operational efficiency.
- Market Cap of $0.00B reflects the company's small size and potential for high volatility.
- Beta of 6.35 indicates a high degree of volatility compared to the overall market.
- Serves federal, state, and private insurance providers, providing a stable revenue base.
Competidores y Pares
Fortalezas
- Specialized service offering in a niche market.
- Established relationships with insurance providers.
- High gross margin (71.5%).
- Experienced management team.
Debilidades
- Negative profit margin (-910.4%).
- Small market capitalization ($0.00B).
- High beta (6.35) indicating high volatility.
- Reliance on insurance reimbursement models.
Catalizadores
- Upcoming: Potential expansion into new geographic markets within the next 2-3 years.
- Upcoming: Diversification of service offerings, including maintenance contracts, within the next 1-2 years.
- Ongoing: Strategic partnerships with healthcare providers to expand customer reach.
- Ongoing: Leveraging technology for remote diagnostics and repair to improve service efficiency.
- Ongoing: Pursuit of government contracts and programs to secure stable revenue streams.
Riesgos
- Potential: Changes in healthcare policies and reimbursement rates impacting revenue.
- Potential: Increased competition from larger DME providers eroding market share.
- Potential: Economic downturn affecting demand for DME services.
- Ongoing: Product liability risks associated with mobility equipment.
- Ongoing: Financial instability due to negative profit margins.
Oportunidades de crecimiento
- Expansion into New Geographic Markets: Proto Script can expand its service area beyond its current base in Rancho Cucamonga, California. Targeting adjacent regions or states with similar demographics and healthcare policies could drive revenue growth. The market for DME repair and rental is fragmented, presenting opportunities for regional expansion. A phased approach, starting with pilot programs in select areas, could mitigate risks and allow for operational adjustments. Timeline: Within the next 2-3 years.
- Diversification of Service Offerings: Proto Script can diversify its service offerings to include maintenance contracts, extended warranties, and training programs for users of power wheelchairs and scooters. These value-added services can generate recurring revenue and enhance customer loyalty. The market for DME-related services is growing, driven by the increasing complexity of mobility equipment and the need for ongoing support. Timeline: Within the next 1-2 years.
- Strategic Partnerships with Healthcare Providers: Proto Script can form strategic partnerships with hospitals, rehabilitation centers, and assisted living facilities to provide on-site repair and rental services. These partnerships can provide access to a larger customer base and streamline the referral process. The healthcare industry is increasingly focused on integrated care models, creating opportunities for collaboration between DME providers and healthcare organizations. Timeline: Within the next 1-2 years.
- Leveraging Technology for Remote Diagnostics and Repair: Proto Script can invest in technology to enable remote diagnostics and repair of power wheelchairs and scooters. This can reduce the need for on-site visits, improve service efficiency, and expand the company's reach. The market for telehealth and remote monitoring is growing rapidly, driven by advancements in technology and the need for cost-effective healthcare solutions. Timeline: Within the next 2-3 years.
- Focus on Government Contracts and Programs: Proto Script can actively pursue government contracts and programs to provide DME repair and rental services to veterans, seniors, and individuals with disabilities. Government contracts can provide a stable source of revenue and enhance the company's reputation. The government is a major purchaser of DME and related services, creating significant opportunities for qualified providers. Timeline: Ongoing.
Oportunidades
- Expansion into new geographic markets.
- Diversification of service offerings (e.g., maintenance contracts).
- Strategic partnerships with healthcare providers.
- Leveraging technology for remote diagnostics and repair.
Amenazas
- Changes in healthcare policies and reimbursement rates.
- Increased competition from larger DME providers.
- Economic downturn affecting demand for DME services.
- Product liability risks associated with mobility equipment.
Ventajas competitivas
- Specialized expertise in power wheelchair and scooter repair.
- Established relationships with insurance providers.
- Focus on a niche market with limited competition.
- Geographic presence in Rancho Cucamonga, California.
Acerca de PSCR
Proto Script Pharmaceutical Corp., established in 2001, operates within the specialty business services sector, focusing on the repair and rental of power wheelchairs and scooters. Headquartered in Rancho Cucamonga, California, the company caters to a specific segment of the healthcare market, providing essential services to individuals requiring mobility assistance. Its primary customer base includes federal, state, and private insurance providers, indicating a reliance on reimbursement models. Proto Script's business model centers around maintaining and leasing mobility equipment, ensuring accessibility and functionality for its clients. The company's founding reflects a response to the growing demand for specialized services within the durable medical equipment (DME) market. Over the years, Proto Script has positioned itself as a service provider, navigating the complexities of insurance claims and regulatory requirements. While the company maintains a presence in a niche market, it faces competition from larger, more diversified players in the broader healthcare and equipment rental industries. Proto Script's success hinges on its ability to efficiently manage its inventory, maintain strong relationships with insurance providers, and adapt to evolving healthcare policies.
Qué hacen
- Repair power wheelchairs and scooters.
- Rent power wheelchairs and scooters.
- Serve federal insurance providers.
- Serve state insurance providers.
- Serve private insurance providers.
- Provide mobility solutions for individuals with disabilities.
Modelo de Negocio
- Generate revenue through repair services for power wheelchairs and scooters.
- Generate revenue through rental services for power wheelchairs and scooters.
- Contract with federal, state, and private insurance providers for reimbursement.
- Maintain and manage a fleet of power wheelchairs and scooters for rental purposes.
Contexto de la Industria
Proto Script Pharmaceutical Corp. operates within the specialty business services sector, which is part of the broader industrials sector. This sector includes companies that provide specialized services to other businesses, often in niche markets. The market for durable medical equipment (DME), including power wheelchairs and scooters, is influenced by factors such as the aging population, prevalence of chronic diseases, and healthcare policies. Competition includes both specialized DME providers and larger healthcare companies. Proto Script's focus on repair and rental differentiates it from companies primarily engaged in sales.
Clientes Clave
- Individuals with disabilities requiring mobility assistance.
- Federal insurance providers (e.g., Medicare).
- State insurance providers (e.g., Medicaid).
- Private insurance providers.
Finanzas
Gráfico e información
Precio de la acción de Proto Script Pharmaceutical Corp. (PSCR): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para PSCR.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para PSCR.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para PSCR.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de PSCR en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Clasificación
Industria Specialty Business ServicesLiderazgo: Michelle Rico
CEO
Michelle Rico serves as the CEO of Proto Script Pharmaceutical Corp. Her background includes experience in healthcare management and operations. Prior to joining Proto Script, she held leadership positions at various healthcare service providers, focusing on improving operational efficiency and customer satisfaction. She has a strong understanding of the durable medical equipment (DME) market and the complexities of insurance reimbursement. Her expertise lies in strategic planning, financial management, and team leadership.
Historial: Under Michelle Rico's leadership, Proto Script Pharmaceutical Corp. has focused on expanding its service offerings and strengthening its relationships with insurance providers. She has overseen the implementation of new technologies to improve service efficiency and enhance customer experience. Her strategic decisions have contributed to the company's growth in a competitive market. She has also focused on improving the company's financial performance, addressing the challenges of negative profit margins.
Información del mercado OTC de PSCR
The OTC Other tier represents the lowest tier of the OTC market, indicating that Proto Script Pharmaceutical Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. It is crucial for investors to conduct thorough due diligence before investing in these companies.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Lack of regulatory oversight.
- Higher risk of business failure.
- Verify the company's registration and legal status.
- Obtain and review all available financial statements.
- Assess the company's management team and their experience.
- Understand the company's business model and competitive landscape.
- Evaluate the company's risk factors and potential liabilities.
- Check for any regulatory actions or legal disputes.
- Consult with a qualified financial advisor.
- Established business operations since 2001.
- Focus on serving insurance providers.
- Presence in a niche market with specialized services.
- CEO with experience in healthcare management.
- Physical headquarters in Rancho Cucamonga, California.
Preguntas Comunes Sobre PSCR
¿Cuáles son los factores clave para evaluar PSCR?
Evaluar PSCR implica revisar los fundamentales, el consenso de analistas y los factores de riesgo. Fortaleza clave: Specialized service offering in a niche market.. Riesgo principal a monitorear: Potential: Changes in healthcare policies and reimbursement rates impacting revenue.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de PSCR?
El MoonshotScore califica a PSCR de 0 a 100 en salud financiera, impulso del mercado y factores de riesgo. Puntuaciones superiores a 70 indican calificaciones más altas, 50-70 moderadas y por debajo de 50 calificaciones más bajas. Se recalcula diariamente. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de PSCR?
Los precios de PSCR se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre PSCR?
La cobertura de analistas para PSCR incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en PSCR?
Las categorías de riesgo para PSCR incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Changes in healthcare policies and reimbursement rates impacting revenue.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de PSCR?
La relación P/E para PSCR compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está PSCR sobrevalorada o infravalorada?
Determinar si Proto Script Pharmaceutical Corp. (PSCR) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de PSCR?
Proto Script Pharmaceutical Corp. (PSCR) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available due to OTC listing and lack of analyst coverage.
- Financial data based on available information and may not be comprehensive.